ClinicalTrials.gov
ClinicalTrials.gov Menu

Metabolomic in Critical Ill Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01506674
Recruitment Status : Recruiting
First Posted : January 10, 2012
Last Update Posted : February 27, 2018
Sponsor:
Information provided by (Responsible Party):
Giovanni Landoni, Università Vita-Salute San Raffaele

Brief Summary:
Analysis of blood, urinary, and intrathecal metabolites of critical ill patients will be checked for possible correlations between metabolomics patterns and patients' outcomes.

Condition or disease
Metabolomic

Study Type : Observational
Observational Model: Cohort
Time Perspective: Prospective
Study Start Date : January 2015
Estimated Primary Completion Date : May 2020
Estimated Study Completion Date : May 2020

Group/Cohort
criticall ill patients



Primary Outcome Measures :
  1. Metabolomic patterns to identify poor outcome [ Time Frame: hospital stay (approximately two weeks) ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 99 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Critical ill patients
Criteria

Inclusion Criteria:

  • patients with severe left or right ventricular dysfunction undergoing cardiac surgery
  • patients undergoing ablation of ventricular tachycardia
  • patients with febrile neutropenia after chemotherapy or allogeneic transplant for haematological diseases
  • patients undergoing thoracoabdominal vascular surgery

Exclusion Criteria:

  • pregnant women
  • no written consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01506674


Locations
Italy
Università Vita-Salute San Raffaele Recruiting
Milano, Mi, Italy, 20132
Contact: Giovanni Landoni       landoni.giovanni@hsr.it   
Contact: Laura Pasin       pasin.laura@hsr.it   
Sponsors and Collaborators
Università Vita-Salute San Raffaele

Responsible Party: Giovanni Landoni, MD, Associate Professor, Università Vita-Salute San Raffaele
ClinicalTrials.gov Identifier: NCT01506674     History of Changes
Other Study ID Numbers: HSR CEmet
First Posted: January 10, 2012    Key Record Dates
Last Update Posted: February 27, 2018
Last Verified: February 2018